康妇消炎栓联合塞克硝唑治疗慢性盆腔炎80例疗效观察  被引量:7

Efficacy of Kangfuxiaoyan Suppository combined with Secnidazole in 80 cases of patients with chronic pelvic inflammatory disease

在线阅读下载全文

作  者:程简 劳海陶 

机构地区:[1]广东省吴川市妇幼保健院,广东吴川524500

出  处:《中国医药导报》2010年第20期49-49,51,共2页China Medical Herald

摘  要:目的:探讨康妇消炎栓联合塞克硝唑治疗慢性盆腔炎的临床疗效。方法:将120例慢性盆腔炎患者随机分为治疗组和对照组,治疗组使用康妇消炎栓直肠给药同时口服塞克硝唑,对照组进行传统抗感染治疗,治疗1~3个疗程,比较治疗结果。结果:治疗组总有效率为97.5%,对照组为85.0%,两组比较,有显著性差异(P<0.05)。结论:康妇消炎栓直肠给药联合塞克硝唑口服治疗慢性盆腔炎效果显著,值得临床推广。Objective:To explore the clinical effects of Kangfuxiaoyan Suppository combined with Secnidazole on chronic pelvic inflammatory disease.Methods:120 case of patients with chronic pelvic inflammatory disease were randomly divided into treatment group and control group,Kangfuxiaoyan Suppository was given by rectal administration,as well Secnida zole was given for oral administration,traditional anti-inflammatory treatment was given in control group,the results after 1-3 course were compared.Results:The total effective rate of the two group were 97.5% and 85.0%,there was a significant difference(P0.05).Conclusion:There is dramatic effect of Kangfuxiaoyan Suppository combined with secnidazole on chronic pelvic inflammatory disease,It's worth to promote clinically.

关 键 词:慢性盆腔炎 康妇消炎栓 塞克硝唑 

分 类 号:R711.33[医药卫生—妇产科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象